Table 1.
The main clinical and laboratory features of 12 healthy subjects and 25 patients diagnosed with severe carotid stenosis
| Characteristics | Control (n = 12) | ASCS (n = 13) | SSCS (n = 12) |
|---|---|---|---|
| Age (years) | 35.07 ± 0.5 | 35.57 ± 4.0 | 43.63 ± 0.5 |
| Male (n, %) | 50% | 30.25% | 66.7% |
| WBC (×109) | 3.78 ± 1.12 | 3.85 ± 2.08 | 3.92 ± 1.73 |
| Neutrophils(%) | 65.62 ± 9.43 | 65.34 ± 7.32 | 71.45 ± 5.26* |
| Monocytes (%) | 2.39 ± 1.12 | 2.40 ± 1.06 | 2.38 ± 1.05 |
| Lymphocytes(%) | 15.34 ± 7.55 | 15.42 ± 7.22 | 15.52 ± 6.78 |
| Esoinophils(%) | 0.30 ± 0.45 | 0.29 ± 0.35 | 0.30 ± 0.42 |
| Basophils(%) | 0 | 0 | 0 |
| Erythrocytes(×1012/L) | 3.87 ± 0.77 | 3.84 ± 0.67 | 3.88 ± 0.49 |
| Hg (g/L) | 122 ± 15.4 | 121 ± 13.6 | 122 ± 12.5 |
| PLT (×109) | 244 ± 42.5 | 245 ± 38.5 | 242 ± 29.5 |
| PT (s) | 12.2 ± 1.0 | 12.1 ± 0.9 | 12.2 ± 0.9 |
| APTT (s) | 33.3 ± 2.1 | 32.7 ± 1.9 | 33.0 ± 1.5 |
| d‐dimer (mg/L) | 348.56 ± 4.1 | 345.38 ± 5.0 | 352.35 ± 5.6 |
| Fibrinogen (mg/L) | 2.66 ± 0.58 | 2.67 ± 0.65 | 2.71 ± 0.47 |
Note: Data are presented as numbers (percentages) or the median ± SD. The main clinical and laboratory features of 12 healthy subjects and 25 patients diagnosed with severe carotid stenosis.
Abbreviations: ASCS, asymptomatic sever carotid stenosis: Hb, hemoglobin; PLTs, platelets; SSCS, symptomatic sever carotid stenosis; WBC, white blood cells.
*
p < .05 versus healthy control.